Jan N.M. IJzermans
Researcher Next ID · RN-033641
Researcher · Medicine
Rotterdam, Netherlands
- Works count
- 962
- Citation count
- 35,963
- H-index
- 89
- i10-index
- 515
Research interests
Publications
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Journal of Hepatology · 2022 · https://doi.org/10.1016/j.jhep.2021.12.010
Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids
Cell stem cell · 2021 · https://doi.org/10.1016/j.stem.2021.04.005
Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis
Journal of Hepatology · 2021 · https://doi.org/10.1016/j.jhep.2021.11.006
Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference
Transplantation · 2020 · https://doi.org/10.1097/tp.0000000000003174
Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance
Cellular and Molecular Gastroenterology and Hepatology · 2020 · https://doi.org/10.1016/j.jcmgh.2020.09.003
Surgery for cholangiocarcinoma
Liver International · 2019 · https://doi.org/10.1111/liv.14089
Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
Gastroenterology · 2017 · https://doi.org/10.1053/j.gastro.2017.06.017
Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
Cell · 2014 · 10.1016/j.cell.2014.11.050
Early Recurrence After Liver Resection for Colorectal Metastases: Risk Factors, Prognosis, and Treatment. A LiverMetSurvey-Based Study of 6,025 Patients
Annals of Surgical Oncology · 2013 · https://doi.org/10.1245/s10434-013-3421-8
Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer
Hepatology · 2012 · https://doi.org/10.1002/hep.26013
Current projects
No projects listed.